Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
United States of America et al v. Advanced Biohealing, Inc.
Case Number:
8:11-cv-00176
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
April 19, 2022
Ex-Attys For Dermagraft Whistleblower Nab $6M Fee Award
The former counsel for an Advance Biohealing Inc. whistleblower can claim $6.13 million in fees from his settlement, despite their former client claiming they hid one attorney's dire health and allowed a disbarred attorney to work on the case, a Florida federal judge ruled Tuesday.
-
December 09, 2021
3rd Fla. Federal Judge Recuses Himself In Battle Over Fees
A third Florida federal district court judge has recused himself from a biotech whistleblower case, saying he once worked as a defense attorney for a former Shire and Advanced BioHealing Inc. employee whose previous company is the subject of the whistleblower complaint.
-
November 30, 2021
Judge Says Attys For Biotech Whistleblower Should Get $6M
A Florida magistrate judge recommended Monday that the former counsel of a whistleblower, who helped reach a $350 million settlement with biotech company Shire, be awarded more than $6 million in the fight over attorney fees related to the settlement.
-
February 22, 2021
Atty Contests Legal Lender's Entry In $350M Shire Fee Row
An attorney representing the former counsel for a whistleblower who helped secure a $350 million settlement with biotech company Shire told a Florida federal court Monday that it lacks authority to allow a law firm lender to intervene in a fees dispute and expressed distrust of the lender's intentions.
-
February 04, 2021
Litigation Funder Wants Cut Of $350M Shire Deal
Law firm lender Counsel Financial Services asked a Florida federal judge Wednesday for permission to intervene in a dispute over divvying up attorney fees from a $350 million whistleblower settlement with biotech company Shire, alleging the law firm Barry A. Cohen PA should be forced to direct any fees it receives to pay back a $43.8 million line of credit.
-
January 15, 2020
Ex-Attys Can't DQ New Counsel In $350M Shire Deal
The attorneys who used to represent a whistleblower failed Tuesday to get a Florida federal judge to disqualify the whistleblower's new attorneys in their fight over a cut of the attorney fee award in a $350 million deal with biotech company Shire Pharmaceuticals PLC.
-
April 09, 2019
Ex-Attys Seek To DQ New Counsel Handling $350M Shire Deal
The former lawyers of a whistleblower who helped reach a $350 million settlement with biotech company Shire over its marketing of a skin product have asked a Florida federal court to disqualify two attorneys and their firm for allegedly using stolen confidential emails to cut the former counsel out of a fee award.
-
November 21, 2017
DOJ Cleared To Split Up $350M Shire Deal For Whistleblowers
A Florida federal judge signed off Monday on the U.S. Department of Justice's apportionment plans for payouts from a $350 million False Claims Act settlement with biotech company Shire, with two of six whistleblower suits getting more than 95 percent of the proceeds, which must still be tabulated.